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Docking protein Gab1 coordinates downstream signaling pathways of 
various receptor tyrosine kinases. Here, we examined the role of Gab1 
in the postnatal angiogenesis through the creation of 
endothelium-specific Gab1 knockout mice (Gab1ECKO). Gab1 ECKO 
did not show any obvious developmental vascular defects. 
Intriguingly, Gab1ECKO displayed severe limb necrosis after 
hindlimb ischemia (HLI), while control mice did not show limb 
necrosis. Among various angiogenic factors such as VEGF, FGF2, and 
hepatocyte growth factor (HGF), HGF stimulation induced the 
strongest tyrosine-phosphorylation of Gab1 and complex formation of 
Gab1 with tyrosine phosphatase SHP2 and PI3-kinase subunit p85 in 
HUVECs. While Gab1-SHP2 complex was required for activation of 
both ERK1/2 and ERK5, Gab1-p85 complex was required for 
activation of AKT after stimulation with HGF. Using DNA 
microarray, we found that Gab1-SHP2 complex was required for the 
upregulation of Kruppel-like factor 2 (KLF2), a crucial transcriptional 
factor for endothelial maintenance in HUVECs. Furthermore, 
MEK5-ERK5 pathway was involved in HGF-induced upregulation of 
KLF2. In addition, the expression of KLF2 in the endothelium was 
significantly decreased in the Gab1ECKO, compared with control 
mice after HLI. These findings indicate that Gab1 is essential for 
HGF-dependent endothelial signaling and postnatal angiogenesis after 
ischemia, presumably via activation of ERK5-KLF2 pathway.
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Abnormal vascular smooth muscle contraction (vasospasm) is 
one of the crucial phenomena which cause cardiac angina and 
brain infarction. We previously found that 
sphingosylphosphorylcholine (SPC) activates Rho-kinase 
(ROK) through the activation of Fyn, a member of Src family 
tyrosine kinase, inducing abnormal vascular smooth muscle 
contraction. However, the target(s) of Fyn, which lead to the 
activation of ROK, are unidentified. In the present study, we 
attempted to identify potential candidates for the target(s) of 
Fyn, by focused proteomics. Since Fyn is supposed to 
tyrosine-phosphorylate the target molecule(s), the 
tyrosine-phosphorylated proteins were enriched from the 
SPC-stimulated human coronary artery smooth muscle cell 
lysates, using an immunoprecipitation with 
anti-phosphotyrosine antibody. Those tyrosine-phosphorylated 
proteins were separated by SDS-PAGE, transferred to PVDF 
membrane, and digested with LysC. We excised 59 protein 
bands from the PVDF membrane, and identified 21 kinds of 
proteins out of 17 bands, using nanoLC-tandem mass 
spectrometry. Those identified proteins included six 
cytoskeleton-related proteins, five transport-related proteins, 
and three enzymes. Further studies are needed to determine 
which one(s) truly activate ROK to induce vasospasm. We 
found that focused proteomic approach is useful to reveal 
possible targets of Fyn, and their functional roles are under 
investigation.
The role of the innate immune system in the development of a 
collateral circulation  
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It is known that physical forces outside the physiological range, can activate 
the innate immune system (IIS). This became known when it was shown 
that LPS, the classical activator of the IIS (via TNF-alpha and iNOS), is a 
stimulant of the growth of collateral arteries following an arterial occlusion. 
The physical force initiating collateral growth is chronically increased fluid 
shear stress driven by the pressure gradient along the occlusion-spanning 
arterioles. We tested the hypothesis whether augmented and prolonged 
increase of fluid shear stress by creating a shunt between the distal stump of 
the occluded artery with the accompanying vein would lead to increased 
growth of collateral vessels. This was the case and it led to completely 
normalized and overshooting function.  Grossly enlarged collateral vessels 
were harvested and their RNA subjected to genome wide screening by 
micro-array and 360 differentially regulated transcripts where found. These 
could be classified into shear stress-sensitive genes, like klf2, ion-channels 
like TRPV4, actin binding proteins like Abra, Thymosin beta 4, destrin, 
cofilin, smoothelin and SMmyosin heavy chain, the NO-generating 
enzymes eNOS and iNOS, and transcription factors like carp. The pattern 
of expression was dominated by the phenotypic change of smooth muscle 
as it undergoes transformation from the contractile to the proliferative and 
synthetic phenotype. From our present and past studies the following 
sequence of events can be deduced: chronically increased shear stress leads 
to early activation of klf2, TRPV4 and eNOS, which activates VEGF 
production via NO to start endothelial proliferation. A so far poorly defined 
endothelial signal reaches the smooth muscular media and stimulates SM 
proliferation after above described phenotype change. Abra plays a 
dominant role because it is a Rho-activating protein with mitogenic 
properties and its inhibition blocks arteriogenesis. Shear stressed 
endothelium but also the transforming muscular media excrete MCP-1 
leading to attraction and adhesion of monocytes that initiate positive 
remodeling of the collateral structure via activation of matrix 
metallo-proteinase and elastase, produce TNF-alpha and iNOS and create a 
peri-vascular inflammation. Genetic or pharmacologic inhibition of the IIS, 
via TNF-alpha, iNOS, MCP-1, collateral artery growth could be completely 
abolished. We conclude that arteriogenesis is dependent on the innate 
immune system when it is activated by a physical stimulus, e.g., fluid shear 
stress.  
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Abacavir is an antiviral nucleoside analogue effectively used 
to treat HIV infection. However, a study showed that the use 
of abacavir significantly increased the risks of stroke and 
myocardial infraction. We sought to investigate the effects of 
abacavir on vascular and platelet activities so as to understand 
the underlying mechanisms. Sprague-Dawley rats (330-350 g) 
were fed with abacavir (16 mg/kg/day, equivalent to the 
clinical dosage on human) for 28 days by gastric gavage. 
Isometric tensions of basilar arteries were measured. Aorta 
mRNA and proteins expressions of various factors related to 
endothelial function and inflammation were measured by 
RT-PCR and Western blotting, respectively. To measure the 
effect of abacavir on platelet activation, the plasma levels of 
CD40L, a platelet-derived factor which is released upon 
platelet activation, were measured by ELISA kit. Our results 
showed that abacavir treatment did not affect the maximum 
relaxation response of basilar artery. Besides, there were no 
significant change in the mRNA and protein expression levels 
of eNOS, COX-1, COX-2 and ICAM-1 in aorta after abacavir 
treatment. However, a higher plasma level of CD40L was 
detected in the abacavir-treated group. It is suggested that 
abacavir does not affect vascular contractility nor induced 
endothelial inflammation. However, abacavir upregulates the 
platelet activity, which will theoretically increase the chance of 
developing thrombosis. This may be a possible explanation for 
the higher risk of cardiovascular events in patients receiving 
abacavir treatment. 
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